Ads
related to: j diabetes investig 2 plus
Search results
Results From The WOW.Com Content Network
The Journal of Diabetes Investigation is a bimonthly peer-reviewed medical journal covering the study of diabetes. It was established in 2010 and is published by John Wiley & Sons on behalf of the Asian Association for the Study of Diabetes , of which it is the official journal.
The Journal of Diabetes is a monthly peer-reviewed medical journal that covers research, therapeutics, and education in the field of diabetes mellitus. It is published by Wiley and is an official journal of the Chinese Society of Endocrinology and endorsed by the Chinese Endocrinologist Association .
When used for assessing the integrity of the hypothalamic–pituitary–adrenal axis (HPA), insulin injections are continued to the point of inducing extreme hypoglycemia below 2.2 mmol/L (40 mg/dL). Patient must have symptomatic neuroglycopenia to trigger counter-regulatory cascade. Glucose levels below 2.2 mmol/L are insufficient absent symptoms.
A large study of more than 2 million people evaluated benefits and risks of GLP-1 agonists. The study showed that GLP-1 agonists reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimer’s disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions [5].
Journal of Diabetes and Endocrine Practice; Journal of Diabetology (not to be confused with Journal of Diabetology published by Allied Academies) Journal of Digestive Endoscopy; Journal of Dr. NTR University of Health Sciences; Journal of Education and Ethics in Dentistry; Journal of Education and Health Promotion
Empagliflozin, sold under the brand name Jardiance (/ ˈ dʒ ɑːr d i ə n s / JAR-dee-əns), among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. [12] [2] [14] It is taken by mouth. [2]
Ad
related to: j diabetes investig 2 plus